CRISPR Market: Global Market Size, Dynamics, Trends, Competitor Analysis, and Forecast, 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global CRISPR Market: By Product Type (Vector-based Cas, DNA-free Cas), By Application (Functional Genomics, Knockdown/activation, Genome Engineering, Disease models, Other Applications), By Distribution Channel (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

CRISPR Market size is valued at USD 1,087.2 million in 2021 and is expected to reach USD 5,068.9 million by 2028, at a CAGR of 24.6% during the forecast period 2022-2028. CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeat. CRISPR is also called as CRISPR/Cas9. The scientific world is attracted by this revolutionary technology. CRISPR technology is a simple yet powerful tool that is used for editing genomes. This technology is used to alter the DNA sequence and modify gene function. Its major application includes correcting genetic defects, treating, and preventing the spread of diseases and is also used improving crops. The technological advancements are the key factors attributed for the growth of the CRISPR market. Increase in the prevalence of genetic and growing drug discovery activities are expected to boost the market revenue growth. The growing demand for synthetic genes and increase in the R&D expenditure on biotechnology and raising government expenditure on genetic research is enriching the growth of the CRISPR market. However, complications such as gene editing of germ line cells are hindering the growth of the market. Since the changes made in germ line cells are transferred to the next generations. The gene editing of germ line cells also has ethical issues and is illegal in most of the countries such as the UK. Limited awareness is another factor hindering the growth of the CRISPR market. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global CRISPR Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global CRISPR Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

CRISPR Market

MARKET SUMMARY
-
24.6%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 24.6%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

CRISPR Market

  • The global CRISPR Market report gives comprehensive outlook on CRISPR Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global CRISPR Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
  • In February 2018, Millipore Sigma has received the Korean Intellectual Property Office and the Israel Patent Office patents for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells.
key players
  • Transposagen Biopharmaceuticals (U.S)
  • Agilent Technologies, Inc. (U.S)
  • Merck KGaA (Germany)
  • Rockland Immunochemicals, Inc. (U.S)
  • Applied StemCell, Inc. (U.S)
CRISPR Market

DRIVERS AND RESTRAINTS

During the projected period, technological developments in CRISPR and the launch of anti-CRISPR proteins are expected to drive the market. The market is predicted to develop due to the growing acceptance of CRISPR technology in pharmaceuticals, epigenetics, plant genome editing, human germline editing, and other disciplines of biotechnology. CRISPR-Cas systems also have uses in culture immunisation, self-targeted cell death, bacterial strain typing, and altering metabolic pathways to increase biochemical synthesis, all of which contribute to the global market’s expansion.


North-America got significant share

CRISPR Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

CRISPR Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Executive Summary
  2. Global CRISPR Market Introduction
    • Global CRISPR Market – Taxonomy
    • Global CRISPR Market –Definitions
      • Product Type
      • Application
      • End User
  1. Global CRISPR Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global CRISPR Market Dynamic Factors – Impact Analysis
    • Global CRISPR Market – Competition Landscape
    • Epidemiology
  2. Global CRISPR Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global CRISPR Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Vector-based Cas
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • DNA-free Cas
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global CRISPR Market Forecast, By Application, 2013 – 2017 and Forecast, 2018 – 2024
    • Functional Genomics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Knockdown/activation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Genome Engineering
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Disease models
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other Applications
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global CRISPR Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Biotechnology & Pharmaceutical Companies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Academic & Government Research Institutes
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global CRISPR Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global CRISPR Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Region, 2018 – 2024
  2. North America CRISPR Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America CRISPR Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2018 – 2024
    • North America CRISPR Market Dynamics – Trends
  3. Europe CRISPR Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe CRISPR Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2018 – 2024
    • Europe CRISPR Market Dynamics – Trends
  4. Asia-Pacific CRISPR Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific CRISPR Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2018 – 2024
    • Asia-Pacific CRISPR Market Dynamics – Trends
  5. Latin America CRISPR Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America CRISPR Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2018 – 2024
    • Latin America CRISPR Market Dynamics – Trends
  6. Middle East and Africa CRISPR Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Vector-based Cas
      • DNA-free Cas
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Functional Genomics
      • Knockdown/activation
      • Genome Engineering
      • Disease models
      • Other Applications
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Biotechnology & Pharmaceutical Companies
      • Academic & Government Research Institutes
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA CRISPR Market – Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2018 – 2024
    • MEA CRISPR Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Transposagen Biopharmaceuticals (U.S)
      • Agilent Technologies, Inc. (U.S)
      • Merck KGaA (Germany)
      • Rockland Immunochemicals, Inc. (U.S)
      • Applied StemCell, Inc. (U.S)
      • Cellecta, Inc. (U.S)
      • GeneCopoeia, Inc. (U.S)
      • Horizon Discovery plc (UK)
      • Mirus Bio LLC (U.S)
      • New England Biolabs (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • Transposagen Biopharmaceuticals (U.S)
  • Agilent Technologies, Inc. (U.S)
  • Merck KGaA (Germany)
  • Rockland Immunochemicals, Inc. (U.S)
  • Applied StemCell, Inc. (U.S)
  • Cellecta, Inc. (U.S)
  • GeneCopoeia, Inc. (U.S)
  • Horizon Discovery plc (UK)
  • Mirus Bio LLC (U.S)
  • New England Biolabs (U.S)

Description

CRISPR Market size is valued at USD 1,087.2 million in 2021 and is expected to reach USD 5,068.9 million by 2028, at a CAGR of 24.6% during the forecast period 2022-2028. CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeat. CRISPR is also called as CRISPR/Cas9. The scientific world is attracted by this revolutionary technology. CRISPR technology is a simple yet powerful tool that is used for editing genomes. This technology is used to alter the DNA sequence and modify gene function. Its major application includes correcting genetic defects, treating, and preventing the spread of diseases and is also used improving crops. The technological advancements are the key factors attributed for the growth of the CRISPR market. Increase in the prevalence of genetic and growing drug discovery activities are expected to boost the market revenue growth. The growing demand for synthetic genes and increase in the R&D expenditure on biotechnology and raising government expenditure on genetic research is enriching the growth of the CRISPR market. However, complications such as gene editing of germ line cells are hindering the growth of the market. Since the changes made in germ line cells are transferred to the next generations. The gene editing of germ line cells also has ethical issues and is illegal in most of the countries such as the UK. Limited awareness is another factor hindering the growth of the CRISPR market. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global CRISPR Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global CRISPR Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX